Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 27;15(7):1451.
doi: 10.3390/v15071451.

Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution?

Affiliations
Review

Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution?

Chuan-Han Deng et al. Viruses. .

Abstract

Inflammasome activation is exclusively involved in sensing activation of innate immunity and inflammatory response during viral infection. Accumulating evidence suggests that the manipulation of inflammasome assembly or its interaction with viral proteins are critical factors in viral pathogenesis. Results from pilot clinical trials show encouraging results of NLRP3 inflammasome suppression in reducing mortality and morbidity in SARS-CoV-2-infected patients. In this article, we summarize the up-to-date understanding of inflammasomes, including NLRP3, AIM2, NLRP1, NLRP6, and NLRC4 in various viral infections, with particular focus on RNA viruses such as SARS-CoV-2, HIV, IAV, and Zika virus and DNA viruses such as herpes simplex virus 1. We also discuss the current achievement of the mechanisms involved in viral infection-induced inflammatory response, host defense, and possible therapeutic solutions.

Keywords: host defense; inflammasome; inflammatory response; innate immunity; therapy; viral infection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Comparison of different inflammasomes. The PYD domain and the CARD domain of ASC serve as anchor points for the assembly of inflammasomes. However, NLRC4 itself carries the CARD domain, so ASC is not required to form the NLRC4 inflammasome. The figure was created in BioRender.
Figure 2
Figure 2
Compositions of different inflammasomes. Most of the identified inflammasomes are composed of NLR proteins, with the exception of NLR4, which recruits ASC by interacting with the PYD domain. The PYD and CARD domains of ASC serve as anchor points for subsequent recruitment of procaspase 1 to complete inflammasome assembly. NLRC4 itself carries the CARD domain, so it interacts directly with procaspase 1 and ASC is not required to form the NLRC4 inflammasome. The figure was created in BioRender.
Figure 3
Figure 3
SARS-CoV-2 activates the NLRP3 inflammasome through multiple pathways. SARS-CoV-2 infects macrophages through the Fcγ receptor. Viral proteins, such as S protein and NSP2, also stimulate NLRP3 transcription dependent on NF-κB signaling. N protein of SARS-CoV-2 directly interacts with NLRP3 to induce inflammasome formation and subsequent inflammatory response. dsDNA released from infected epithelial cells and mtDNA released from damaged mitochondria can also activate the inflammasome. The figure was created in BioRender.

Similar articles

Cited by

References

    1. Ogura Y., Sutterwala F.S., Flavell R.A. The inflammasome: First line of the immune response to cell stress. Cell. 2006;126:659–662. doi: 10.1016/j.cell.2006.08.002. - DOI - PubMed
    1. Chen Q.L., Yin H.R., He Q.Y., Wang Y. Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease. Biomed. Pharm. 2021;138:111442. doi: 10.1016/j.biopha.2021.111442. - DOI - PubMed
    1. Diamond M.S., Kanneganti T.D. Innate immunity: The first line of defense against SARS-CoV-2. Nat. Immunol. 2022;23:165–176. doi: 10.1038/s41590-021-01091-0. - DOI - PMC - PubMed
    1. Prochnicki T., Vasconcelos M.B., Robinson K.S., Mangan M.S.J., De Graaf D., Shkarina K., Lovotti M., Standke L., Kaiser R., Stahl R., et al. Mitochondrial damage activates the NLRP10 inflammasome. Nat. Immunol. 2023;24:595–603. doi: 10.1038/s41590-023-01451-y. - DOI - PubMed
    1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727–733. doi: 10.1056/NEJMoa2001017. - DOI - PMC - PubMed

Publication types

Substances